EXPRESSION OF AEG-1 AND P53 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN MALIGNANT LESIONS OF RENAL CELL CARCINOMAS: A MICROARRAY STUDY

被引:18
作者
Erdem, Havva [1 ]
Oktay, Murat [1 ]
Yildirim, Umran [2 ]
Uzunlar, Ali Kemal [1 ]
Kayikci, M. Ali [1 ]
机构
[1] Duzce Univ, Fac Med, Dept Pathol, Duzce, Turkey
[2] Fatih Univ, Fac Med, Dept Pathol, Ankara, Turkey
关键词
AEG-1; p53; prognostic parameters; renal cell carcinomas; ASTROCYTE ELEVATED GENE-1; BREAST-CANCER; TUMOR PROGRESSION; OVEREXPRESSION; IDENTIFICATION; HYBRIDIZATION; ENVELOPE; SURVIVAL; PATHWAY; PROTEIN;
D O I
10.5114/PJP.2013.34600
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to investigate the relationship of AEG-1 and p53 with the prognostic parameters of renal cell carcinoma (RCC). In this study, 50 paraffin blocks were histopathologically diagnosed at the Department of Pathology of the Medical Hospital of Duzce University, between 2005 and 2011. The cases consisted of 24 clear cell (CC) and 26 non-clear cell (NCC) RCC subtypes as follows: 24 (48%) clear cell RCC, 12 (24%) papillary RCC, 4 (8%) multilocular cystic RCC and 10 (20%) chromophobe RCC; none had sarcornatoid changes. By immunohistochemical analysis we investigated AEG-1 and p53 expression in carcinomas of the kidney, and by statistical analysis determined their relationship with clinicopathological parameters. Significant relationships were found between increasing tumor diameter and the increase of p53 (p = 0.028). In addition, p53 was significantly related to renal sinus invasion (p = 0.05) and Fuhrman grade (p = 0.026). There was a significant relationship between increased AEG-1 staining scores and CC and NCC carcinoma subtypes (p = 0.032), tumor capsule invasion (p = 0.01) and lymphovascular invasion (p = 0.015). There was also a significant correlation between tumor size and capsule and lymphovascular invasion (p = 0.02). We concluded that high AEG-1 and p53 expression correlates with the prognostic parameters in RCC patients, and in addition may be associated with tumor progression.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 31 条
[1]   Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma [J].
Baytekin, Firat ;
Tuna, Burcin ;
Mungan, Ugur ;
Aslan, Guven ;
Yorukoglu, Kutsal .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (05) :502-507
[2]   Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells [J].
Britt, DE ;
Yang, DF ;
Yang, DQ ;
Flanagan, D ;
Callanan, H ;
Lim, YP ;
Lin, SH ;
Hixson, DC .
EXPERIMENTAL CELL RESEARCH, 2004, 300 (01) :134-148
[3]   Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression [J].
Carroll, PE ;
Okuda, M ;
Horn, HF ;
Biddinger, P ;
Stambrook, PJ ;
Gleich, LL ;
Li, YQ ;
Tarapore, P ;
Fukasawa, K .
ONCOGENE, 1999, 18 (11) :1935-1944
[4]   Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression [J].
Chen, W. ;
Ke, Z. ;
Shi, H. ;
Yang, S. ;
Wang, L. .
NEOPLASMA, 2010, 57 (06) :522-529
[5]   Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma [J].
Cho, DS ;
Joo, HJ ;
Oh, DK ;
Kang, JH ;
Kim, YS ;
Lee, KB ;
Kim, SJ .
YONSEI MEDICAL JOURNAL, 2005, 46 (01) :133-140
[6]   Systemic Therapy for Metastatic Non-Clear-Cell Renal Cell Carcinoma: Recent Progress and Future Directions [J].
Chowdhury, Simon ;
Matrana, Marc R. ;
Tsang, Christopher ;
Atkinson, Bradley ;
Choueiri, Toni K. ;
Tannir, Nizar M. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2011, 25 (04) :853-+
[7]   Renal cell carcinoma [J].
Curti, BD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (01) :97-100
[8]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[9]   p53 mutations and other prognostic factors of renal cell carcinoma [J].
Girgin, C ;
Tarhan, H ;
Hekimgil, M ;
Sezer, A ;
Gürel, G .
UROLOGIA INTERNATIONALIS, 2001, 66 (02) :78-83
[10]  
Hodorova I, 2012, BIOMED PAP, DOI [10.5507/bp.2012.035, DOI 10.5507/BP.2012.035]